This inventor holds 1 USPTO granted patent. Top assignee: Sanofi Pasteur Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Reynald Cobert: Innovator in Pharmaceutical Packaging
Introduction
Reynald Cobert is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceutical packaging. His innovative approach has led to the development of a unique internal cardboard support designed to enhance the packaging of pharmaceutical products.
Latest Patents
Reynald Cobert holds a patent for an "Internal cardboard support for receiving pharmaceutical products, packaging and method for packaging." This invention features a main compartment with a housing specifically designed to accommodate a primary pharmaceutical item. The design includes a bottom wall and two edge members that extend from the bottom wall, creating a structure that is both functional and efficient. Each edge member is designed with multiple wall portions, ensuring a parallelepipedic shape that extends longitudinally along the main compartment. Additionally, at least one edge member forms an extra compartment for receiving additional pharmaceutical items.
Career Highlights
Reynald Cobert is currently associated with Sanofi Pasteur Inc., a leading company in the pharmaceutical industry. His work focuses on improving packaging solutions that ensure the safety and integrity of pharmaceutical products. His innovative designs have the potential to revolutionize how these products are packaged and delivered.
Collaborations
Throughout his career, Reynald has collaborated with talented individuals such as Teddy Klein and Benoit Kunz. These partnerships have fostered a creative environment that encourages innovation and the development of new ideas in pharmaceutical packaging.
Conclusion
Reynald Cobert's contributions to pharmaceutical packaging demonstrate his commitment to innovation and excellence. His patent for an internal cardboard support showcases his ability to address industry needs effectively. As he continues to work with Sanofi Pasteur Inc., his impact on the field is likely to grow even further.